Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells. Carter BZ, Mak PY, Muftuoglu M, Tao W, et al. Blood 2023;142:1056-1070.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carter BZ, Mak PY, Muftuoglu M, Tao W, et al. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells. Blood 2023;142:1056-1070.
PMID: 37339579